| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anti-CD19 CAR T cells for refractory myasthenia gravis
|
Haghikia, Aiden
|
|
|
22 |
12 |
p. 1104-1105
|
artikel
|
| 2 |
Anticoagulation in people with atrial fibrillation after intracranial haemorrhage
|
Uchiyama, Shinichiro
|
|
|
22 |
12 |
p. 1091-1092
|
artikel
|
| 3 |
Balancing the scales of adversity: a socioecological approach to reducing the global burden of stroke and cardiovascular disease
|
Brusca, Samuel B
|
|
|
22 |
12 |
p. 1094-1096
|
artikel
|
| 4 |
Carlayne Jackson: leading the American Academy of Neurology
|
Samarasekera, Udani
|
|
|
22 |
12 |
p. 1106
|
artikel
|
| 5 |
Carotid artery overtreatment in the USA
|
Abbott, Anne
|
|
|
22 |
12 |
p. 1102-1103
|
artikel
|
| 6 |
Classic ketogenic diet versus further antiseizure medicine in infants with drug-resistant epilepsy (KIWE): a UK, multicentre, open-label, randomised clinical trial
|
Schoeler, Natasha E
|
|
|
22 |
12 |
p. 1113-1124
|
artikel
|
| 7 |
Correction to Lancet Neurol 2023; 22: 1160–206
|
|
|
|
22 |
12 |
p. e13
|
artikel
|
| 8 |
Correction to Lancet Neurol 2023; 22: 812–25
|
|
|
|
22 |
12 |
p. e13
|
artikel
|
| 9 |
Dementia in Japan: a societal focus
|
Kinoshita, Shotaro
|
|
|
22 |
12 |
p. 1101-1102
|
artikel
|
| 10 |
Digital mobility measures to predict Parkinson's disease
|
Mirelman, Anat
|
|
|
22 |
12 |
p. 1098-1100
|
artikel
|
| 11 |
Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials
|
Al-Shahi Salman, Rustam
|
|
|
22 |
12 |
p. 1140-1149
|
artikel
|
| 12 |
Epilepsy stigma: a long story
|
Weatherall, Mark
|
|
|
22 |
12 |
p. 1107
|
artikel
|
| 13 |
Eugenia Martínez
|
|
|
|
22 |
12 |
p. 1107
|
artikel
|
| 14 |
Expansion of stenting indications in the USA
|
Ramos, Alexander D
|
|
|
22 |
12 |
p. 1103
|
artikel
|
| 15 |
Gene therapy for X-linked myotubular myopathy: the challenges
|
Voermans, Nicol C
|
|
|
22 |
12 |
p. 1089-1091
|
artikel
|
| 16 |
Immune-checkpoint inhibitors and neurological adverse events
|
Tummala, Sudhakar
|
|
|
22 |
12 |
p. 1093-1094
|
artikel
|
| 17 |
Medical Nemesis 50 years on
|
Lees, Andrew J
|
|
|
22 |
12 |
p. 1111
|
artikel
|
| 18 |
Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study
|
Fonseca, Elianet
|
|
|
22 |
12 |
p. 1150-1159
|
artikel
|
| 19 |
Policy priorities for preventing stroke-related mortality and disability worldwide
|
Watkins, David A
|
|
|
22 |
12 |
p. 1096-1098
|
artikel
|
| 20 |
Powerful series profiles rare forms of dementia
|
Ranscombe, Peter
|
|
|
22 |
12 |
p. 1112
|
artikel
|
| 21 |
Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
|
Feigin, Valery L
|
|
|
22 |
12 |
p. 1160-1206
|
artikel
|
| 22 |
Prevention of dementia with holistic brain health
|
Hachinski, Vladimir
|
|
|
22 |
12 |
p. 1101
|
artikel
|
| 23 |
Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial
|
Shieh, Perry B
|
|
|
22 |
12 |
p. 1125-1139
|
artikel
|
| 24 |
The global challenge of hypertension
|
The Lancet Neurology,
|
|
|
22 |
12 |
p. 1087
|
artikel
|
| 25 |
The (hi)story of stroke
|
Brigo, Francesco
|
|
|
22 |
12 |
p. 1110
|
artikel
|
| 26 |
The wisdom of our mentors: clinical pearls in movement disorders
|
Araújo, Rui
|
|
|
22 |
12 |
p. 1108-1109
|
artikel
|
| 27 |
Treatment of drug-resistant epilepsy: diet or pill?
|
Patel, Manisha
|
|
|
22 |
12 |
p. 1088-1089
|
artikel
|
Tijdschrift beschrijving